Cite
Platelet-rich plasma (PRP) in oncological patients – Long term comparative analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients
MLA
LA Fischer, et al. “Platelet-Rich Plasma (PRP) in Oncological Patients – Long Term Comparative Analysis of the Treatment of Subcutaneous Venous Access Device Scars in 89 Breast Cancer Patients.” Senologie - Zeitschrift Für Mammadiagnostik Und -Therapie, May 2019. EBSCOhost, https://doi.org/10.1055/s-0039-1687959.
APA
LA Fischer, Wolfram Malter, M Warm, Johannes Holtschmidt, J. Üner, Christian Eichler, & F Thangarajah. (2019). Platelet-rich plasma (PRP) in oncological patients – Long term comparative analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients. Senologie - Zeitschrift Für Mammadiagnostik Und -Therapie. https://doi.org/10.1055/s-0039-1687959
Chicago
LA Fischer, Wolfram Malter, M Warm, Johannes Holtschmidt, J. Üner, Christian Eichler, and F Thangarajah. 2019. “Platelet-Rich Plasma (PRP) in Oncological Patients – Long Term Comparative Analysis of the Treatment of Subcutaneous Venous Access Device Scars in 89 Breast Cancer Patients.” Senologie - Zeitschrift Für Mammadiagnostik Und -Therapie, May. doi:10.1055/s-0039-1687959.